According to the Hong Kong Stock Exchange, Newbridge Biotech has submitted a listing application to the Hong Kong Stock Exchange, with Goldman Sachs and CITIC Securities acting as joint sponsors.
2025-10-31
According to the Hong Kong Stock Exchange, Newbridge Biotech has submitted a listing application to the Hong Kong Stock Exchange, with Goldman Sachs and CITIC Securities acting as joint sponsors.